Search
site map
IP Handbook Blog
Your source for expert commentary on IP management issues.
Go to the blog
About
MIHR
PIPRA
Fiocruz, Brazil
bioDevelopments- Institute
|
CHAPMAN, Junko
Junko has been a Research Associate at MIHR (Centre for the Management of Intellectual Property in Health Research and Development) since April 2005. Before MIHR, she spent ten years at RIKEN (The Institute for Physical and Chemical Research), a semi-governmental research institute in Japan. At RIKEN, Junko’s responsibilities included conclusion of MTAs (Material Transfer Agreements) and collaborative research agreements and management of RIKEN’s intellectual property portfolio. Junko was also heavily involved in establishing a system for disseminating RIKEN’s key inventions internationally. These inventions included RIKEN’s mouse cDNA clones, which have since become globally recognized and widely used.
Junko graduated from SPRU (Science and Technology Policy Research), University of Sussex, in 2001, where she received her M.Sc. in Science and Technology Policy, during which time she focused, in part, on the impact of harmonization of patent systems. Junko is also a graduate of GRIPS (National Graduate Institute for Policy Studies, Japan), where she received a Master in International Development Studies in 2005.
Abstract
Current Issues of IP Management for Health and Agriculture in Japan
Abstract:
This chapter describes current and historical trends and issues related to intellectual property (IP) management in Japan. It gives a history of Japan’s national IP system in order to provide an understanding of the nature of the system and why and how it was established. The chapter also describes current government efforts to provide insights into the system’s future. With regard to current IP issues, two topical issues are discussed: industry-university collaboration on R&D and employees’ inventions. Japan’s efforts to resolve these issues may be helpful for other countries that are grappling with similar issues.
The chapter also details health and agricultural IP issues in Japan. It discusses and compares with the practices of other countries the patentability of medical methods and exemptions for the experimental use of patented products. Furthermore, the chapter offers an overview of Japan’s national policy on agricultural R&D and biore-source centers (the functioning of which greatly involves the transfer of materials with IP rights). RIKEN (The Institute of Physical and Chemical Research) is offered as a case study to clarify the policies and issues discussed.
Finally, for the benefit of other countries that are coming to terms with IP management issues, the chapter offers some lessons learned by Japan that have helped shape its national IP policy, strategy, and institutional IP management.
|